Protein kinase C expression is deregulated in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 54, Issue 10, 2013, Pages 2288-2290

  Kabir, Nuzhat N ^a   Rönnstrand, Lars ^b   Kazi, Julhash U ^a,b  

^a KN Biomedical Research Institute   (Bangladesh)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA;

BREAST CANCER; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; DONOR; EPIGENETICS; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; LETTER; LUNG CANCER; MACROGLOBULINEMIA; MICROARRAY ANALYSIS; MYELOMA; ONCOGENE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UPREGULATION;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROTEIN KINASE C; RNA ISOFORMS;

EID: 84879417048     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.769220     Document Type: Letter

References (15)

1. Kabir NN, Kazi JU. Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversity. Genet Mol Biol 2011; 34: 587-591.
2. Kazi JU, Kabir NN, Soh JW. Bioinformatic prediction and analysis of eukaryotic protein kinases in the rat genome. Gene 2008; 410: 147-153.
3. Kazi JU. The mechanism of protein kinase C regulation. Front Biol 2011; 6: 328-336.
4. Kazi JU, Soh JW. Induction of the nuclear proto-oncogene c-fos by the phorbol ester TPA and v-H-Ras. Mol Cells 2008; 26: 462-467.
5. Ruvolo PP, Zhou L, Watt JC, et al. Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells. J Cell Biochem 2011; 112: 1696-1707.
6. Riches JC, Ramsay AG, Gribben JG. Chronic lymphocytic leukemia: An update on biology and treatment. Curr Oncol Rep 2011; 13: 379-385.
7. Washburn L. Chronic lymphocytic leukemia: The most common leukemia in adults. JAAPA 2011; 24: 54-58 Quiz 59.
8. Schnaiter A, Mertens D, Stilgenbauer S. Genetics of chronic lymphocytic leukemia. Clin Lab Med 2011; 31: 649-658.
9. Pan Q, Bao LW, Kleer CG, et al. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res 2005; 65: 8366-8371.
10. Zhang J, Liu N, Zhang J, et al. PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosisinducing ligand-mediated apoptosis. J Cell Biochem 2005; 96: 522-532.
11. Alkan S, Huang Q, Ergin M, et al. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Am J Hematol 2005; 79: 97-106.
12. Abrams ST, Lakum T, Lin K, et al. B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CbetaII. Blood 2007; 109: 1193-1201.
13. zum Buschenfelde CM, Wagner M, Lutzny G, et al. Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70. Leukemia 2010; 24: 141-152.
14. Holler C, Pinon JD, Denk U, et al. PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: Validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia. Blood 2009; 113: 2791-2794.
15. Barragan M, de Frias M, Iglesias-Serret D, et al. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: Role of protein kinase C{beta}. J Leukoc Biol 2006; 80: 1473-1479.